BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8985357)

  • 1. The Epstein-Barr virus EBNA-1 promoter Qp requires an initiator-like element.
    Nonkwelo C; Ruf IK; Sample J
    J Virol; 1997 Jan; 71(1):354-61. PubMed ID: 8985357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-independent and -induced regulation of Epstein-Barr virus EBNA-1 gene transcription in Burkitt lymphoma.
    Nonkwelo C; Ruf IK; Sample J
    J Virol; 1997 Sep; 71(9):6887-97. PubMed ID: 9261415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repression of Epstein-Barr virus EBNA-1 gene transcription by pRb during restricted latency.
    Ruf IK; Sample J
    J Virol; 1999 Oct; 73(10):7943-51. PubMed ID: 10482541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autorepression of Epstein-Barr virus nuclear antigen 1 expression by inhibition of pre-mRNA processing.
    Yoshioka M; Crum MM; Sample JT
    J Virol; 2008 Feb; 82(4):1679-87. PubMed ID: 18077719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcription start sites downstream of the Epstein-Barr virus (EBV) Fp promoter in early-passage Burkitt lymphoma cells define a fourth promoter for expression of the EBV EBNA-1 protein.
    Nonkwelo C; Skinner J; Bell A; Rickinson A; Sample J
    J Virol; 1996 Jan; 70(1):623-7. PubMed ID: 8523583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-barr virus nuclear antigen 3C activates the latent membrane protein 1 promoter in the presence of Epstein-Barr virus nuclear antigen 2 through sequences encompassing an spi-1/Spi-B binding site.
    Zhao B; Sample CE
    J Virol; 2000 Jun; 74(11):5151-60. PubMed ID: 10799590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the Epstein-Barr virus Fp promoter.
    Nonkwelo C; Henson EB; Sample J
    Virology; 1995 Jan; 206(1):183-95. PubMed ID: 7831773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constitutive activation of Epstein-Barr virus (EBV) nuclear antigen 1 gene transcription by IRF1 and IRF2 during restricted EBV latency.
    Schaefer BC; Paulson E; Strominger JL; Speck SH
    Mol Cell Biol; 1997 Feb; 17(2):873-86. PubMed ID: 9001242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Epstein-Barr virus latency BamHI-Q promoter is positively regulated by STATs and Zta interference with JAK/STAT activation leads to loss of BamHI-Q promoter activity.
    Chen H; Lee JM; Wang Y; Huang DP; Ambinder RF; Hayward SD
    Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9339-44. PubMed ID: 10430944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon regulatory factor 7 is induced by Epstein-Barr virus latent membrane protein 1.
    Zhang L; Pagano JS
    J Virol; 2000 Feb; 74(3):1061-8. PubMed ID: 10627515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reciprocal regulation of the Epstein-Barr virus BamHI-F promoter by EBNA-1 and an E2F transcription factor.
    Sung NS; Wilson J; Davenport M; Sista ND; Pagano JS
    Mol Cell Biol; 1994 Nov; 14(11):7144-52. PubMed ID: 7935429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms that regulate Epstein-Barr virus EBNA-1 gene transcription during restricted latency are conserved among lymphocryptoviruses of Old World primates.
    Ruf IK; Moghaddam A; Wang F; Sample J
    J Virol; 1999 Mar; 73(3):1980-9. PubMed ID: 9971778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of EBNA-1 mRNA is regulated by cell cycle during Epstein-Barr virus type I latency.
    Davenport MG; Pagano JS
    J Virol; 1999 Apr; 73(4):3154-61. PubMed ID: 10074167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Host factors LR1 and Sp1 regulate the Fp promoter of Epstein-Barr virus.
    Bulfone-Paus S; Dempsey LA; Maizels N
    Proc Natl Acad Sci U S A; 1995 Aug; 92(18):8293-7. PubMed ID: 7667284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines.
    Schaefer BC; Strominger JL; Speck SH
    Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10565-9. PubMed ID: 7479841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EBNA-2 upregulation of Epstein-Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1.
    Ling PD; Hsieh JJ; Ruf IK; Rawlins DR; Hayward SD
    J Virol; 1994 Sep; 68(9):5375-83. PubMed ID: 8057421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel promoter located within the Bam HI Q region of the Epstein-Barr virus genome for the EBNA 1 gene.
    Tsai CN; Liu ST; Chang YS
    DNA Cell Biol; 1995 Sep; 14(9):767-76. PubMed ID: 7669254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon regulatory factor 2 represses the Epstein-Barr virus BamHI Q latency promoter in type III latency.
    Zhang L; Pagano JS
    Mol Cell Biol; 1999 Apr; 19(4):3216-23. PubMed ID: 10082588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Epstein-Barr virus major latent promoter Qp is constitutively active, hypomethylated, and methylation sensitive.
    Tao Q; Robertson KD; Manns A; Hildesheim A; Ambinder RF
    J Virol; 1998 Sep; 72(9):7075-83. PubMed ID: 9696800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Residues 231 to 280 of the Epstein-Barr virus nuclear protein 2 are not essential for primary B-lymphocyte growth transformation.
    Harada S; Yalamanchili R; Kieff E
    J Virol; 1998 Dec; 72(12):9948-54. PubMed ID: 9811732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.